Get the Stockscreener App
17.81
0.34%
0.06
After Hours:
17.81
Abrdn Life Sciences Investors stock is traded at $17.81, with a volume of 92,701.
It is up +0.34% in the last 24 hours and up +8.80% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
See More
Previous Close:
$17.75
Open:
$17.83
24h Volume:
92,701
Relative Volume:
0.75
Market Cap:
$541.57M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+3.31%
1M Performance:
+8.80%
6M Performance:
+8.27%
1Y Performance:
+51.45%
1-Day Range:
$17.74
$17.96
1-Week Range:
$17.08
$17.96
52-Week Range:
$11.59
$17.96
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL vs DNP, UTG, UTF, ADX, GDV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
17.81 | 539.74M | 0 | 0 | 0 | 0.00 |
DNP
Dnp Select Income Fund Inc
|
10.49 | 3.95B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
41.82 | 3.83B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
26.37 | 2.96B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
23.85 | 2.91B | 0 | 0 | 0 | 0.00 |
GDV
Gabelli Dividend Income Trust
|
28.96 | 2.52B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
abrdn Life Sciences Investors (NYSE:HQL) Hits New 52-Week HighStill a Buy? - MarketBeat
Aberdeen Investments U.S. Closed-End Funds Announce Distribution Payment Details - ADVFN
Returns Recap: Will Abrdn Life Sciences Investors outperform tech stocks2026 Update & Daily Growth Stock Tips - baoquankhu1.vn
Hedge Fund Bets: Should I hold or sell Abrdn Healthcare Investors now2026 Key Highlights & Expert Verified Movement Alerts - baoquankhu1.vn
Risks Report: Will Abrdn Life Sciences Investors stock recover after earnings2026 Opening Moves & Safe Entry Zone Identification - baoquankhu1.vn
Aug Closing: Will MREO announce a stock split2026 Market Mood & Growth Focused Entry Point Reports - baoquankhu1.vn
Bond Watch: Will Abrdn Life Sciences Investors benefit from rising consumer demandWeekly Risk Summary & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Trustee elections ahead for abrdn healthcare funds (NYSE: HQH) - Stock Titan
Options Flow: Is Abrdn Life Sciences Investors vulnerable to short sellersMarket Growth Review & Long Hold Capital Preservation Tips - baoquankhu1.vn
Tech Rally: Will Abrdn Life Sciences Investors benefit from geopolitical trendsRate Hike & Weekly Top Performers Watchlists - baoquankhu1.vn
Price Action: Can Abrdn Life Sciences Investors sustain earnings growth2026 Valuation Update & Safe Entry Zone Tips - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Update - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
abrdn Life Sciences Investors (NYSE:HQL) Sees Large Increase in Short Interest - MarketBeat
Aug Weekly: Can Abrdn Life Sciences Investors sustain earnings growth2026 Trade Ideas & Safe Capital Growth Plans - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Stock Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat
Earnings Report: Is Abrdn Life Sciences Investors benefiting from innovation trends2026 Support & Resistance & Verified Short-Term Plans - baoquankhu1.vn
Income Plays: Will Abrdn Life Sciences Investors stock recover after earningsMarket Trend Summary & Reliable Trade Execution Plans - baoquankhu1.vn
Short Interest in abrdn Life Sciences Investors (NYSE:HQL) Decreases By 37.6% - MarketBeat
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Drop in Short Interest - MarketBeat
abrdn Life Sciences Investors (NYSE:HQL) Stock Price Up 2.5%Still a Buy? - MarketBeat
Will Abrdn Life Sciences Investors stock deliver long term returnsJuly 2025 Opening Moves & Long Hold Capital Preservation Tips - Naître et grandir
Sentiment Recap: Can Abrdn Healthcare Investors reach all time highs this year2025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026 (2026-03-06) - Seeking Alpha
First Trust entities jointly hold 3.02M shares of abrdn Life Sciences Investors (HQL) - Stock Titan
THQTekla Funds Urge Shareholders to Vote Immediately to Guarantee Reduced Fund Expenses - mx.advfn.com
HQL PE Ratio & Valuation, Is HQL Overvalued - Intellectia AI
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS - mx.advfn.com
Layoff Watch: Will Abrdn Life Sciences Investors stock hit new highs in YEARDollar Strength & Expert Curated Trade Ideas - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 361.3% in February - Defense World
Sectors Review: Will Abrdn Life Sciences Investors stock hit new highs in YEAR2025 Growth vs Value & Comprehensive Market Scan Insights - baoquankhu1.vn
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
Abrdn World Healthcare Fund Q4 2025 Commentary (THW) - Seeking Alpha
Abrdn Life Sciences Investors Fund Q4 2025 Commentary (HQL) - Seeking Alpha
Aug PreEarnings: Will Calidi Biotherapeutics Inc. stock recover after earningsJuly 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
Aug Swings: Should I hold or sell Abrdn Healthcare Investors nowRecession Risk & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Saba Capital details 4.95% stake in abrdn Life Sciences (HQL) - Stock Titan
Abrdn Healthcare Opportunities Fund Q4 2025 Commentary - Seeking Alpha
What is Abrdn Life Sciences Investors s 5 year growth outlookWeekly Trend Report & Technical Pattern Based Signals - mfd.ru
Will Abrdn Life Sciences Investors benefit from rising consumer demandJuly 2025 Update & Verified Entry Point Signals - mfd.ru
Abrdn Healthcare Investors Fund Q4 2025 Commentary - Seeking Alpha
Aug Macro: Can THCH reach all time highs this yearQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 (2026-02-19) - Seeking Alpha
Abrdn Life Sciences Investors To Go Ex-Dividend On February 20th, 2026 With 0.56 USD Dividend Per Share - 富途牛牛
abrdn Healthcare Investors (NYSE:HQH) Reaches New 12-Month HighTime to Buy? - MarketBeat
Abrdn Healthcare Investors stock hits 52-week high at $19.98 By Investing.com - Investing.com Australia
Will Abrdn Life Sciences Investors stock recover after earningsTake Profit & Fast Moving Stock Watchlists - mfd.ru
Market Catalysts: How volatile is Abrdn Life Sciences Investors stockJuly 2025 Review & Fast Entry Momentum Alerts - baoquankhu1.vn
abrdn Healthcare Investors (NYSE:HQH) Sees Significant Decline in Short Interest - MarketBeat
Shareholders who lost money in shares of Mereo BioPharma Group PLC (NASDAQ: MREO) should contact Wolf Haldenstein immediately (2026-02-14) - Seeking Alpha
Why Abrdn Life Sciences Investors stock is favored by top institutionsEarnings Beat & Community Shared Stock Ideas - mfd.ru
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Abrdn Life Sciences Investors Stock (HQL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Saba Capital Management, L.P. | 10% Owner |
Sep 22 '25 |
Sale |
14.14 |
41,623 |
588,549 |
2,837,633 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 19 '25 |
Sale |
14.10 |
6,989 |
98,545 |
2,879,256 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 18 '25 |
Sale |
14.07 |
40,208 |
565,727 |
2,886,245 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 17 '25 |
Sale |
13.99 |
24,328 |
340,349 |
2,926,453 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 16 '25 |
Sale |
13.99 |
2,026 |
28,344 |
2,950,781 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 15 '25 |
Sale |
14.13 |
700 |
9,891 |
2,952,807 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 11 '25 |
Sale |
14.28 |
15,116 |
215,856 |
2,953,507 |
| Saba Capital Management, L.P. | 10% Owner |
Sep 02 '25 |
Sale |
14.04 |
14,083 |
197,725 |
2,968,623 |
| Saba Capital Management, L.P. | 10% Owner |
Aug 29 '25 |
Sale |
13.89 |
23,723 |
329,512 |
2,982,706 |
| Saba Capital Management, L.P. | 10% Owner |
Aug 26 '25 |
Sale |
13.83 |
400 |
5,532 |
3,006,429 |
0.39%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):